VisionGraft Expansion
Ocular Surface Reconstruction, Glaucoma Surgery
CommercialActive
Key Facts
Indication
Ocular Surface Reconstruction, Glaucoma Surgery
Phase
Commercial
Status
Active
Company
About CorneaGen
CorneaGen is a commercial-stage company and a world-leading eye bank specializing in corneal transplant tissue and regenerative medicine. Its core offering is CTAK, a gamma-irradiated, sterile, and customized corneal tissue inlay, alongside a portfolio of surgical products like the EndoSerter and VisionGraft. The company leverages its extensive tissue processing capabilities, surgeon education programs, and strategic partnerships to address corneal blindness, positioning itself as an integrated provider in the ophthalmic surgery ecosystem.
View full company profile